• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG DC BOULDER FORCETRIAD; ELECTROSURGICAL, CUTTING & COAGULATION & ACCES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG DC BOULDER FORCETRIAD; ELECTROSURGICAL, CUTTING & COAGULATION & ACCES Back to Search Results
Model Number FORCETRIAD
Medical Device Problem Codes Device Alarm System (1012); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); Unspecified Tissue Injury (4559)
Date of Event 06/13/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
D10 concomitant product: bz4212, open sealer/div bz4212 bizact 5mm-12cm (lot#: 40430231x).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
According to the reporter,5 to 8 days post tonsillectomy, patient had moderate, continuous bilateral and diffuse bleeding about 250 - 500 cc at the site of the sealed dissection.The bleeding occured in various areas around the surgical site where the device was used.Blood transfusion was not required but it was necessary to re-operate patient for additional suture.During the revision surgery, surgeon claimed that the specific tissue around the surgical site was already damaged from the device in the previous surgery.Patient was treated by sealing tonsillar pillars and with tachosil patch.During the original procedure, there was no activation tone and end tone but there were incomplete cycle error occurred.Patient was not taking any medications prior to procedure and did not received chemotherapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FORCETRIAD
Common Device Name
ELECTROSURGICAL, CUTTING & COAGULATION & ACCES
Manufacturer (Section D)
COVIDIEN MFG DC BOULDER
5920 longbow dr
boulder CO 80301 3299
Manufacturer (Section G)
COVIDIEN MFG DC BOULDER
5920 longbow dr
boulder CO 80301 3299
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key19735916
Report Number1717344-2024-01478
Device Sequence Number8375824
Product Code GEI
UDI-Device Identifier10884524001531
UDI-Public10884524001531
Combination Product (Y/N)N
Initial Reporter CountryIT
PMA/510(K) Number
K110268
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberFORCETRIAD
Device Catalogue NumberFORCETRIAD
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/20/2024
Initial Report FDA Received Date07/12/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE NOTE ON H11
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age12 YR
Patient SexUnknown
-
-